Literature DB >> 21632499

Identifying patients with follicular lymphoma who are likely to benefit from an idiotype vaccine.

Stephen M Ansell, Vera J Suman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21632499     DOI： 10.1200/JCO.2011.35.8812

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Idiotype vaccination as consolidation therapy: time for integration into standard of care for follicular lymphoma?

Authors:  Stephen J Schuster; Sattva S Neelapu; Carlos F Santos; Mihaela A Popa-McKiver; Amy M McCord; Larry W Kwak
Journal:  J Clin Oncol       Date:  2011-10-31       Impact factor: 44.544

Review 2.  Successes, failures and new perspectives of idiotypic vaccination for B-cell non-Hodgkin lymphomas.

Authors:  Elena Muraro; Debora Martorelli; Riccardo Dolcetti
Journal:  Hum Vaccin Immunother       Date:  2013-02-13       Impact factor: 3.452
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.